Vir
Powering the Immune System to Transform Lives
- Headquarters
- San Francisco, California
- Employees
- 201–500
- Business Model
- B2B
About
Vir Biotechnology leverages the immense potential of the immune system to address critical unmet medical needs and improve patient outcomes. Its pipeline is built on two technology platforms — a next-generation antibody platform and the PRO-XTEN protease-releasable masking technology — applied to infectious diseases and oncology. The company has broken ground in immunology, engineering antibody-based medicines for COVID-19 and Ebola, with a leading program in chronic hepatitis delta and strategic programs in oncology.
Summary
Vir is a Biotech company based in San Francisco, United States.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...